Your browser doesn't support javascript.
loading
Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell Lymphoma.
Alonso-Álvarez, Sara; Alcoceba, Miguel; García-Álvarez, María; Blanco, Oscar; Rodríguez, Marta; Baile, Mónica; Caballero, Juan Carlos; Dávila, Julio; Vidriales, María Belén; Esteban, Carmen; Arias, Piedad; Díaz, Luis G; Tamayo, Pilar; Caballero, María Dolores; Gutiérrez, Norma C; González, Marcos; Martín, Alejandro.
Afiliación
  • Alonso-Álvarez S; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Alcoceba M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • García-Álvarez M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Blanco O; Department of Pathology, University Hospital of Salamanca (HUS/IBSAL), 37007 Salamanca, Spain.
  • Rodríguez M; Department of Pathology, University Hospital of Salamanca (HUS/IBSAL), 37007 Salamanca, Spain.
  • Baile M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Caballero JC; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Dávila J; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Vidriales MB; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Esteban C; Department of General and Gastrointestinal Surgery, University Hospital of Salamanca (HUS/IBSAL), 37007 Salamanca, Spain.
  • Arias P; Department of Radiology, University Hospital of Salamanca (HUS/IBSAL), 37007 Salamanca, Spain.
  • Díaz LG; Department of Nuclear Medicine, University Hospital of Salamanca (HUS/IBSAL), 37007 Salamanca, Spain.
  • Tamayo P; Department of Nuclear Medicine, University Hospital of Salamanca (HUS/IBSAL), 37007 Salamanca, Spain.
  • Caballero MD; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Gutiérrez NC; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • González M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
  • Martín A; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), CIBERONC, and Cancer Research Institute of Salamanca-IBMCC (CSIC-USAL University), 37007 Salamanca, Spain.
Cancers (Basel) ; 12(2)2020 Feb 18.
Article en En | MEDLINE | ID: mdl-32085520
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: España